GLP-1 receptor agonists

The weight loss drugs Wegovy and Ozempic portend a massive impact on the “obesity epidemic.”  Users may even be able to get insurance coverage, as the FDA just approved a third drug specifically for weight loss treatment, signaling greater coverage for all drugs in the class. Sounds promising, right? But, alas, there are unintended consequences.